CJC-1295 with DAC vs Somatropin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
CJC-1295 with DAC is a long-acting GHRH analog that uses a Drug Affinity Complex (DAC) technology - a reactive maleimidoproprionic acid linker that covalently bonds to plasma albumin after injection. This albumin binding dramatically extends its half-life to 6-8 days, allowing on...
Calculate CJC-1295 with DAC dose →Somatropin is recombinant human growth hormone (rhGH) - a 191 amino acid protein identical to endogenous pituitary GH, produced via recombinant DNA technology. It is FDA-approved for multiple indications including pediatric and adult growth hormone deficiency, Turner syndrome, HI...
Calculate Somatropin dose →| Parameter | CJC-1295 with DAC | Somatropin |
|---|---|---|
| Category | Growth Hormone & IGF | Growth Hormone & IGF |
| Research | Research Use | FDA Approved |
| Half-Life | 6–8 days | ~3–4 hours (SubQ); ~20 min (IV) |
| Typical Dose | 1,000–2,000 µg | 0.1–0.3 mg/day (GHD); up to 2 mg/day (clinical indications) |
| Frequency | Once or twice weekly | Daily or 6 days/week |
| Route | Subcutaneous | Subcutaneous / Intramuscular |
| FDA Status | Not Approved | Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.